Home/Filings/4/0001077183-21-000111
4//SEC Filing

Mallon Mark 4

Accession 0001077183-21-000111

CIK 0001077183other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 6:19 PM ET

Size

6.8 KB

Accession

0001077183-21-000111

Insider Transaction Report

Form 4
Period: 2021-04-19
Mallon Mark
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-04-19+151,016151,016 total
    Exercise: $49.34Exp: 2028-04-19Common Stock (151,016 underlying)
  • Award

    Common Stock

    2021-04-19+55,73655,736 total
Footnotes (1)
  • [F1]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001763533

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 6:19 PM ET
Size
6.8 KB